JL

Jeffrey Langfield

Director of Quality Assurance & Regulatory Affairs at CorVent Medical

Jeffrey Langfield has extensive experience in the medical industry, particularly in quality assurance and regulatory affairs. Jeffrey is currently serving as the Director of Quality Assurance & Regulatory Affairs at Corvent Medical Inc. since October 2021. Prior to this, they held the role of Director of Quality & Regulatory Affairs at Corvida Medical from July 2014 to October 2021. Before joining Corvida Medical, Jeffrey worked as the Principal Quality Assurance Engineer at Mendell from December 2012 to July 2014. Jeffrey also served as the Director of Quality at Zyga Technology, Inc. from July 2010 to November 2012. Jeffrey's earlier experiences include roles at Advanced Circulatory Systems, Inc. as the Director of Quality & Regulatory Affairs from October 2004 to August 2010, and as the Principal Quality Engineer from March 2004 to October 2004. Jeffrey worked as a Senior Quality Engineer at ev3 from May 1999 to March 2004. Additionally, Jeffrey gained experience as a Quality Engineer - New Product Development at Boston Scientific - Scimed from July 1998 to May 1999 and as a Product Development Engineer at Schneider Worldwide (Acquired by Boston Scientific in June 1998) from March 1988 to July 1998.

Jeffrey Langfield's education history includes studying Mechanical Engineering at the University of Minnesota. However, no specific start or end years or degree completion information are provided.

Location

Rosemount, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


CorVent Medical

CorVent Medical has developed a simple, yet sophisticated, RESPOND ventilation platform to meet the majority of the global patient needs. The RESPOND Ventilator is designed and manufactured in the U.S. and delivers a compact, 15 pound (7 kg) ventilator to accommodate both clinical and stockpile needs. allowing for rapid and easy deployment. TheRESPOND ventilator platform has been tested to the ICU primary ventilation standard (ISO 80601-2-12) and has been intentionally designed to guarantee maintenance-free quality and reliability with unmatched shelf life stability for an extended lifecycle and a low total cost of ownership.


Industries

Employees

11-50

Links